InsiderTrades

Form 4 for JNJ Johnson & Johnson

Accepted 2026-06-12 17:23:31 ET · period of report 2026-06-11 · accession 0000200406-26-000127 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-06-12 17:23 2026-06-11 JNJ Wengel Kathryn E EVP, Chief TO, Risk Off M - OptEx $115.67 +10.0K 124.3K +9% +$1.16M
D 2026-06-12 17:23 2026-06-11 JNJ Wengel Kathryn E EVP, Chief TO, Risk Off S - Sale+OE $241.15 -10.0K 114.3K -8% -$2.41M
D 2026-06-12 17:23 2026-06-11 JNJ Wengel Kathryn E EVP, Chief TO, Risk Off M - OptEx $0.00 -10.0K 33.0K -23% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-06-11 M A 10,000 $115.67 124,287.87 D — —
2 Common Common Stock 2026-06-11 S D 10,000 $241.15 114,287.87 D — — (F1) This transaction was executed in multiple trades at prices ranging from $240.14 to $240.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
3 Derivative Employee Stock Options (Right to Buy) 2026-06-11 M D 10,000 $0.00 32,965 D $115.67 · 2020-02-13 to 2027-02-13 10,000 Common Stock (F4) Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.